However, 45% of the non-TB patients in this study had immunologic failure (an increase of <50 CD4+ cells/μl) at 6 months, while 32% failed to restore CD4+ T cell count to ≥ 200 cells/μl by 2 years on ART, which is similar to a study from Nigeria[38]. This evidence concerns the gene CD4 and tuberculosis.